Bill > HB1809

This bill establishes a comprehensive medical psilocybin program in New Hampshire, allowing carefully supervised therapeutic use of psilocybin for patients with specific qualifying conditions such as treatment-resistant depression, post-traumatic stress disorder, and substance use disorders. The program will be administered by the Department of Health and Human Services, which will create a structured framework for approving and regulating medical providers who can both produce and administer psilocybin. Providers must undergo a detailed application process, including providing personal information, professional credentials, and specifics about their production and treatment locations. A dedicated medical psilocybin advisory board will be established to monitor the program, consisting of experts from various medical and healthcare fields, who will review clinical outcomes, best practices, and potential program expansions. The bill provides legal exemptions for approved providers producing and administering therapeutic doses of psilocybin to qualified patients, while maintaining strict criminal penalties for any unauthorized use. The program will not automatically take effect but is contingent upon the advisory board certifying its readiness within two years of the act's passage, with the intent of creating a carefully controlled medical intervention for patients with serious, treatment-resistant conditions.

Budget and Finance, Health and Social Services

https://gc.nh.gov/bill_Status/billinfo.aspx?id=1700&inflect=2